Plasmapheresis in Systemic Lupus Erythematosus: Facts and Perspectives

5. Huang C., del Greco F., Ivanovich P., Krumlovsky F.A, Roguska J., Simon N.M. and Hano J.: Maintenance dialysis for diabetic nephropathy with uremia. J. Chron. Dis. 28:365-374, 1975. 6. Totten M.A, Izenstein B., Gleason R.E., Takacs F.J., Libertino J.A, D'Elia J.A: Chronic renal failure in diabetes: survival with hemodialysis vs. transplantation. J. Dialysis 2:17-32,1978. 7. Goetz F.C., Kjellstrand C.M.: The treatment of diabetic kidney disease. Diabetologia 17:267-281, 1979. 8. Jacobs C., Rottembourg J., Frantz P., Slama G. and Legrain M.: Treatment of end-stage renal failure in the insulin-dependent diabetic patient. Year Book Medical Publishers, Inc. 101-126, 1979. 9. Shideman J.R., Buselmeier T.J., Kjellstrand C.M.: Hemodialysis in diabetics. Complications in insulindependent patients accepted for renal transplantation. Arch. Intern, Med. 136:1126-1130, 1976. 10. Vincenti F., Hattner R., Amend W.J. Jr., Feduska N.J., Duca R.M., Salvatierra O. Jr.: Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. JAMA 245:930-933, 1981.

[1]  F. Schena,et al.  Plasma exchange in systemic lupus erythematosus. , 1983, The International journal of artificial organs.

[2]  G. Tsokos,et al.  Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study. , 1982, Clinical and experimental immunology.

[3]  T C Chalmers,et al.  Randomized versus historical controls for clinical trials. , 1982, The American journal of medicine.

[4]  J. Jones,et al.  Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA. , 1981, Arthritis and rheumatism.

[5]  T. Hamblin,et al.  The effect of plasma exchange on the in vitro monocyte function of patients with immune complex diseases. , 1981, Clinical and experimental immunology.

[6]  W. Clark,et al.  Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study. , 1981, Canadian Medical Association journal.

[7]  W. Murphy,et al.  Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. , 1981, Arthritis and rheumatism.

[8]  S. Adler,et al.  Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. , 1980, JAMA.

[9]  A. Steinberg,et al.  Systemic Lupus Erythematosus: Evolving Concepts , 1979 .

[10]  G. Hughes,et al.  Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. , 1979, The Quarterly journal of medicine.

[11]  A. Woodroffe,et al.  Plasmapheresis in glomerulonephritis. , 1979, Clinical nephrology.

[12]  C. Lockwood,et al.  Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. , 1979, The New England journal of medicine.

[13]  G. Eknoyan,et al.  Effect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisone. , 1977, The American journal of medicine.

[14]  T. Hamblin,et al.  PLASMAPHERESIS IN THE MANAGEMENT OF ACUTE SYSTEMIC LUPUS ERYTHEMATOSUS? , 1976, The Lancet.

[15]  R. Kimberly,et al.  A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus. , 1982, Arthritis and rheumatism.